Join the club for FREE to access the whole archive and other member benefits.

Blackrock Neurotech receives $10m funding from Peter Thiel

19-May-2021

Key points from article :

Peter Thiel has backed the firm called Blackrock Neurotech in a $10 million financing round.

It is working on brain-computer interface (BCI) devices, competing with Neuralink.

Targeting their products at people with limited movement and other disabilities.

Blackrock Neurotech claims that it has already put its devices into 28 patients, as well as primates and rodents.

Once implanted, electrodes record neuron activity, amplify the signal of thoughts, and send it to a computer.

Software on the computer then tries to interpret and turns that into commands.

"Neuralink’s device can record more brain cell activity than Blackrock’s BCIs," - Andrew Jackson, Professor at Newcastle University.

Neuralink and Blackrock Neurotech are working on wireless devices.

Blackrock Neurotech wants its devices to be distributed in the same way that pacemakers and cochlear implants are.

“I am confident that in less than 20 years’ time, we will all have a BCI,” - Christian Angermayer, Founder of Apeiron Investment Group.

New competitor for Neuralink's brain implant, streamlining solution for neurological disorders

Mentioned in this article:

Tap on icon for description, click on resource name for more details.

Academic

Professor of Neural Interfaces at Newcastle University.

Company

Neurotechnology firm developing implantable tools

Company Representative

Founder of Apeiron Investment Group and Presight Capital

Company

Company developing high bandwidth brain-machine interfaces to connect humans and machines.

Author

American entrepreneur and venture capitalist.